MiMedx Group Inc (MDXG):企業の財務・戦略的SWOT分析

◆英語タイトル:MiMedx Group Inc (MDXG) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH83319FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥84,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥126,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MiMedx Group Inc (MiMedx) develops, manufactures and markets regenerative biologics utilizing human placental allografts. The company provides products such as amniotic membrane, umbilical cord, placental ECM and amniotic fluid. It utilizes proprietary purion process that separates placental tissues, cleans and reassembles layers, and dehydrates the tissue to preserve the key elements associated with healing. MiMedx’s product delivers human extracellular matrix components for regeneration of damaged or diseased tissues. Its products modulate inflammation, reduce scar tissue formation, and enhance healing. The company offers services in the areas of wound care, burn, surgical, orthopaedic, spine, sports medicine, ophthalmic and dental sectors of healthcare. MiMedx is headquartered in Marietta, Georgia, the US.

MiMedx Group Inc Key Recent Developments

Mar 30,2021: MiMedx awarded amniotic tissue supplier agreement with Premier’s SURPASS Purchasing Program
Mar 08,2021: MiMedx announces fourth quarter and full year 2020 financial and operating results
Mar 03,2021: MiMedx to Participate at Upcoming Investor Conferences

This comprehensive SWOT profile of MiMedx Group Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of MiMedx Group Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

MiMedx Group Inc – Key Information
MiMedx Group Inc – Overview
MiMedx Group Inc – Key Employees
MiMedx Group Inc – Key Employee Biographies
MiMedx Group Inc – Key Operational Heads
MiMedx Group Inc – Major Products and Services
MiMedx Group Inc – History
MiMedx Group Inc – Company Statement
MiMedx Group Inc – Locations And Subsidiaries
MiMedx Group Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

MiMedx Group Inc – Business Description
MiMedx Group Inc – Corporate Strategy
MiMedx Group Inc – SWOT Analysis
SWOT Analysis – Overview
MiMedx Group Inc – Strengths
MiMedx Group Inc – Weaknesses
MiMedx Group Inc – Opportunities
MiMedx Group Inc – Threats
MiMedx Group Inc – Key Competitors

Section 3 – Company Financial Performance Charts

MiMedx Group Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

MiMedx Group Inc, Key Information
MiMedx Group Inc, Key Ratios
MiMedx Group Inc, Share Data
MiMedx Group Inc, Major Products and Services
MiMedx Group Inc, History
MiMedx Group Inc, Key Employees
MiMedx Group Inc, Key Employee Biographies
MiMedx Group Inc, Key Operational Heads
MiMedx Group Inc, Other Locations
MiMedx Group Inc, Subsidiaries
MiMedx Group Inc, Key Competitors
MiMedx Group Inc, SWOT Analysis
MiMedx Group Inc, Ratios based on current share price
MiMedx Group Inc, Annual Ratios
MiMedx Group Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[MiMedx Group Inc (MDXG):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Centogene AG-製薬・医療分野:企業M&A・提携分析
    Summary Centogene AG (Centogene) is a provider of genetic testing services. The company offers genetic testing for rare hereditary disorders. It offers whole genome sequencing, whole exome sequencing, biomarker and biochemical testing; prenatal testing, DNA extraction and cell culture services. Cent …
  • Cooper Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Cooper Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Cooper Energy Limited (CEL) is an exploration and production company that offers oil production programs. The company explores, produces, and commercializes crude oil and natural gas products. It condu …
  • Domino’S Pizza Group Plc:企業の戦略・SWOT・財務分析
    Domino'S Pizza Group Plc - Strategy, SWOT and Corporate Finance Report Summary Domino'S Pizza Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • United Networks Ltd (UNL):企業の財務・戦略的SWOT分析
    United Networks Ltd (UNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Romaero SA Bucuresti:企業の戦略・SWOT・財務分析
    Romaero SA Bucuresti - Strategy, SWOT and Corporate Finance Report Summary Romaero SA Bucuresti - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Irkut Corporation (IRKT):企業の財務・戦略的SWOT分析
    Irkut Corporation (IRKT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Vexim SA – Product Pipeline Analysis, 2018 Uate
    Summary Vexim SA (Vexim), a subsidiary of Stryker Corp, is a healthcare product manufacturer that provides solutions for patients suffering from vertebral compression fractures. The company provides solutions such as controlled anatomical restoration and advanced vertebroplasty therapy. Its controll …
  • InVitae Corp (NVTA):製薬・医療:M&Aディール及び事業提携情報
    Summary Invitae Corp (Invitae), formerly Locus Development Inc, is a genetic information company which processes DNA-containing samples, analyzes information about patient-specific genetic variation and generates test reports for clinicians and their patients. The company’s portfolio of diagnostic t …
  • Vallourec Sa:企業の戦略・SWOT・財務分析
    Vallourec Sa - Strategy, SWOT and Corporate Finance Report Summary Vallourec Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • GAIL (India) Ltd (GAIL):石油・ガス:M&Aディール及び事業提携情報
    Summary GAIL (India) Ltd (GAIL) is a vertically integrated gas company. It carries out processing, transmission and marketing of gas; transmission of liquefied petroleum gas (LPG); re-gasification of liquefied natural gas (LNG); and production and marketing of petrochemicals. The company also has pr …
  • Sapura Energy Bhd (SENERGY):石油・ガス:M&Aディール及び事業提携情報
    Summary Sapura Energy Bhd (Sapura) formerly known as SapuraKencana Petroleum Berhad is a global provider of integrated oil and gas services and solutions. It focuses on upstream business covering exploration, development, production, as well as decommissioning and abandonment stages. The company’s s …
  • TEGNA Inc (TGNA):企業の財務・戦略的SWOT分析
    TEGNA Inc (TGNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Global Insurance Management Limited
    Global Insurance Management Limited - Strategy, SWOT and Corporate Finance Report Summary Global Insurance Management Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Skinvisible Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Skinvisible Pharmaceuticals Inc (Skinvisible Pharmaceuticals), a subsidiary of Skinvisible Inc is a pharmaceutical company that develops and manufactures prescription and over the counter dermatology, medical, cosmetic, consumer goods, and skincare products. The company’s products include an …
  • Phillips 66 (PSX):企業の財務・戦略的SWOT分析
    Phillips 66 (PSX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • iCAD Inc (ICAD):企業の財務・戦略的SWOT分析
    iCAD Inc (ICAD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Cellumed Co Ltd (049180):医療機器:M&Aディール及び事業提携情報
    Summary Cellumed Co Ltd (Cellumed), formerly Korea Bone Bank Inc is a biotechnology company that develops bone graft substitution based on human tissue graft. The company offers allograft tissue products such as bio-clearant, a clearant process that treats tissues with patented chemicals and sterili …
  • Splash Corporation:戦略・SWOT・企業財務分析
    Splash Corporation - Strategy, SWOT and Corporate Finance Report Summary Splash Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • BPS Direct LLC:企業の戦略・SWOT・財務分析
    BPS Direct LLC - Strategy, SWOT and Corporate Finance Report Summary BPS Direct LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Inovise Medical, Inc.:企業の戦略的SWOT分析
    Inovise Medical, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆